Transfusion analyzer, supplies, consumables, services, and materials used to support transfusion services, for the purpose of blood bank testing under a cost-per-test (CPT) agreement.

Active Awarded Last action

Contract number
W81K0025FA130
Awardee
Awarding agency
Obligated
$107,855

Award facts

Contract value 20% obligated
  • $215,709.02 Current, with exercised options
  • $539,272.55 Potential, with all options
Completion date 21% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92121, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00003 · FY27 exercise option year one -transfusion analyzer, supplies, consumables, services, and materials used to support transfusion services, for the purpose of… $0
Other Administrative Action P00002 $107,855
Other Administrative Action P00001 $0
Original award $0

About this award

The Defense Health Agency awarded a delivery order valued at $539,277.59 to Quidelortho Sales Company, LLC for transfusion analyzer supplies, consumables, services, and materials to support blood bank testing operations at a San Diego, California facility. The contract operates under a cost-per-test pricing model and is positioned as a delivery order under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) master schedule. The award carries no set-aside designation and extends through September 30, 2030, with performance at San Diego, CA 92121. Quidelortho Sales Company is a San Diego-based for-profit limited liability company specializing in medical diagnostic equipment and laboratory testing supplies to federal healthcare agencies and maintains HUBZone joint venture certification.

Quidelortho brings substantial relevant experience to this engagement, having established itself as a key supplier within the federal healthcare procurement ecosystem for blood bank and clinical laboratory technologies. The company has secured significant prior Defense Health Agency contracts for cost-per-test chemistry analyzers, immunochemistry systems, and laboratory reagents at military treatment facilities and installations including Fort Campbell, Fort Meade, and Naval Hospital Okinawa. Additionally, Quidelortho maintains extensive contracting relationships across the Department of Veterans Affairs, Indian Health Service, and specialized federal facilities, with current active IDVs and blanket purchase agreements totaling several million dollars across multiple federal agencies through 2030.

Quick answers

Who was awarded contract W81K0025FA130?

W81K0025FA130 was awarded to Quidelortho Sales Company, LLC by Medical Command (Department of the Army) on October 1, 2025.

How much is contract W81K0025FA130 worth?

The government has obligated $107,855 on W81K0025FA130. Its current value, with exercised options, is $215,709. Its potential value, with all options, is $539,273.

Which agency awarded contract W81K0025FA130?

Medical Command (Department of the Army) awarded W81K0025FA130, with funding from Defense Health Agency (Department of Defense).

Is contract W81K0025FA130 an order under another contract?

Yes. W81K0025FA130 is a delivery order under V797D60637, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract W81K0025FA130 competed?

The extent of competition for W81K0025FA130 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award